What I Read This Week...

Grade inflation in ivy league schools, a new FDA approved sickle cell treatment, and a slow EV charging rollout...

Watch All-In E156 Read my Global Energy Transition Deep-Dive Caught my eye… Nearly 80% of all grades given to undergraduates at Yale last academic year were A’s or A-minuses, up from 67% in the 2010-2011 academic year, prompting concerns that higher grades are becoming less valuable. This isn’t unique to Yale - at Harvard, 79% of all grades given to undergraduates in the 2020-21 year were also A’s or A-minuses, up from just 60% a decade earlier. The FDA approved two milestone cell-based gene therapy treatments for sickle cell disease, a rare life-threatening blood disorder caused by…

related reading

• FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease | Scientific Americanscientificamerican.com
• UK first to approve CRISPR treatment for diseases: what you need to knownature.com
• Notes on technology in the 2020selidourado.com
• Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
• Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
• SSC Gives A Graduation Speechslatestarcodex.com
• The Elite Overproduction Hypothesisnoahpinion.blog
• Medicine's Endgamenotboring.co
• Pearl Freier on X: "Cell & gene therapies were 2.5x more likely to receive FDA approval after entering Phase 1 than other drug types according to research by the NEWDIGs initiative at Tufts Medical Center h/t @DrPHanley & @alliancerm . @NatRevDrugDisc paper below 1/n https://t.co/DN4k7qWrAt" / Xx.com
• Dyno Therapeutics: The Capsids You Needcenturyofbio.com
• What I Read This Week...chamath.substack.com
• Medicine's Endgamecenturyofbio.com